NSE
Entero Healthcare Solutions LimitedENTERO
Entero Healthcare Solutions Limited is a pharmaceutical company focused on developing and marketing prescription drugs in India. The company's products are primarily used to treat various gastrointestinal disorders.
| Key products | GastroCare, GastroShield, Gastric Care |
|---|---|
| Geography | India, Middle East, Africa |
| Competitors | Sun Pharma, Cipla, Dr. Reddy's Laboratories |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹5 Cr | 372 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | ENTEROThis | — | — | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 581 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-12FilingOrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) oShareholding Disclosure
- 2026-06-12FilingEntero Healthcare Solutions Limited has informed the Exchange about Resignation of Director/KMP/SMPRisk
- 2026-06-12FilingEntero Healthcare Solutions Limited has informed the Exchange regarding Resignation of Mr KEVIN ROHITBHAI DAFTRisk
- 2026-06-11FilingEntero Healthcare Solutions Limited has informed the Exchange regarding Grant of 17500 Options.ESOP/ESOS/ESPS
- 2026-06-11FilingEntero Healthcare Solutions Limited has informed the Exchange regarding Allotment of 3420 Shares.ESOP/ESOS/ESPS
- 2026-06-11FilingEntero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 1Board Meeting
- 2026-06-09Filing Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities aShareholding Disclosure
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2
- 3
- 2
- 2
- 3
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF →
No bulk/block deals for ENTERO in this window.
Results & transcripts
Financial results
None yet.
News & chatter on ENTERO
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.